Our result was similar to the study mentioned earlier conducted on mice: the deletion of the miR-148 harms hepatic cancer and lipid metabolism by targeting different genes, including ABCA1, and PGC1α [46]. This evidence concerns the gene PPARGC1A and liver cancer.